Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation.
Champagne J, Nielsen MM, Feng X, Montenegro Navarro J, Pataskar A, Voogd R, Giebel L, Nagel R, Berenst N, Fumagalli A, Kochavi A, Lovecchio D, Valcanover L, Malka Y, Yang W, Laos M, Li Y, Proost N, van de Ven M, van Tellingen O, Bleijerveld OB, Haanen JBAG, Olweus J, Agami R.
Champagne J, et al. Among authors: fumagalli a.
Immunity. 2025 Jan 14;58(1):247-262.e9. doi: 10.1016/j.immuni.2024.12.004. Epub 2025 Jan 3.
Immunity. 2025.
PMID: 39755122
Free article.